title: Methicillin-resistant Staphylococcus epidermidis (MRSE) endocarditis treated with linezolid.
abstract: Linezolid is not yet recognized as a standard therapy for infective endocarditis but its use becomes a necessity when infection is due to multidrug-resistant microorganisms. This report describes 1 patient with endocarditis treated with linezolid and 45 similar cases from the medical literature.
authors.affiliation: Clinic of Infectious Diseases, Centre of Excellence on Ageing, University 'G. d'Annunzio' School of Medicine, Chieti-Pescara, Italy.
authors.forename: Paola
authors.initials: P
authors.lastname: Mancino
authors.forename: Claudio
authors.initials: C
authors.lastname: Ucciferri
authors.forename: Katia
authors.initials: K
authors.lastname: Falasca
authors.forename: Eligio
authors.initials: E
authors.lastname: Pizzigallo
authors.forename: Jacopo
authors.initials: J
authors.lastname: Vecchiet
mesh_terms: D000081:Acetamides / Q000627:therapeutic use*; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D006801:Humans; D000069349:Linezolid; D008297:Male; D016106:Methicillin Resistance / Q000187:drug effects*; D023303:Oxazolidinones / Q000627:therapeutic use*; D016459:Prosthesis-Related Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013212:Staphylococcus epidermidis / Q000187:drug effects* / Q000472:pathogenicity
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D000069349:Linezolid